@article {Hasan2020.07.30.20165555, author = {A. Hasan and E.R.M. Putri and H. Susanto and N. Nuraini}, title = {Data-driven modeling and forecasting of COVID-19 outbreak for public policy making}, elocation-id = {2020.07.30.20165555}, year = {2020}, doi = {10.1101/2020.07.30.20165555}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {This paper presents a data-driven approach for COVID-19 outbreak modeling and forecasting, which can be used by public policy and decision makers to control the outbreak through Non-Pharmaceutical Interventions (NPI). First, we apply an extended Kalman filter (EKF) to a discrete-time stochastic augmented compartmental model to estimate the time-varying effective reproduction number ℛt. We use daily confirmed cases, active cases, recovered cases, deceased cases, Case-Fatality-Rate (CFR), and infectious time as inputs for the model. Furthermore, we define a Transmission Index (TI) as a ratio between the instantaneous and the maximum value of the effective reproduction number. The value of TI shows the disease transmission in a contact between a susceptible and an infectious individual due to current measures such as physical distancing and lock-down relative to a normal condition. Based on the value of TI, we forecast different scenarios to see the effect of relaxing and tightening public measures. Case studies in three countries are provided to show the practicability of our approach.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesLink to data and codes is written in the article. https://github.com/agusisma/coviddatadriven}, URL = {https://www.medrxiv.org/content/early/2020/08/02/2020.07.30.20165555}, eprint = {https://www.medrxiv.org/content/early/2020/08/02/2020.07.30.20165555.full.pdf}, journal = {medRxiv} }